Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Proliferation and apoptosis must be precisely regulated to form organs with appropriate cell numbers and to avoid tumour growth. Here we show that Hippo (Hpo), the Drosophila homologue of the mammalian Ste20-like kinases, MST1/2, promotes proper termination of cell proliferation and stimulates apoptosis during development. hpo mutant tissues are larger than normal because mutant cells continue to proliferate beyond normal tissue size and are resistant to apoptotic stimuli that usually eliminate extra cells. Hpo negatively regulates expression of Cyclin E to restrict cell proliferation, downregulates the Drosophila inhibitor of apoptosis protein DIAP1, and induces the proapoptotic gene head involution defective (hid) to promote apoptosis. The mutant phenotypes of hpo are similar to those of warts (wts), which encodes a serine/threonine kinase of the myotonic dystrophy protein kinase family, and salvador (sav), which encodes a WW domain protein that binds to Wts. We find that Sav binds to a regulatory domain of Hpo that is essential for its function, indicating that Hpo acts together with Sav and Wts in a signalling module that coordinately regulates cell proliferation and apoptosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Targeted gene expression as a means of altering cell fates and generating dominant phenotypes
Brand, A. H., & Perrimon, N. (1993) · Development · doi:10.1242/dev.118.2.401 · Cited by 9,612
Green, D. R., & Evan, G. I. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00024-7 · Cited by 1,254
Justice, R. W., Zilian, O., Woods, D. F., Noll, M., & Bryant, P. J. (1995) · Genes & Development · doi:10.1101/gad.9.5.534 · Cited by 977 · cited 1×
“The mutant phenotypes of hpo are similar to those of warts ( wts ), which encodes a serine/threonine kinase of the myotonic dystrophy protein kinase famil”
BackgroundTapon, N., Harvey, K. F., Bell, D. W., Wahrer, D. C. R., Schiripo, T. A., Haber, D. A., & Hariharan, I. K. (2002) · Cell · doi:10.1016/s0092-8674(02)00824-3 · Cited by 856 · cited 1×
“, and salvador ( sav ), which encodes a WW domain protein that binds to Wt”
BackgroundXu, T., Wang, W., Zhang, S., Stewart, R. A., & Yu, W. (1995) · Development · doi:10.1242/dev.121.4.1053 · Cited by 799
Coordination of Growth and Cell Division in the Drosophila Wing
Neufeld, T. P., de la Cruz, A. F. A., Johnston, L. A., & Edgar, B. A. (1998) · Cell · doi:10.1016/s0092-8674(00)81462-2 · Cited by 769 · cited 1×
“jpg" NDATA ITEM> ]> Proliferation and apoptosis must be precisely regulated to form organs with appropriate cell numbers and to avoid tumour growt”
BackgroundSize Control in Animal Development
Conlon, I., & Raff, M. (1999) · Cell · doi:10.1016/s0092-8674(00)80563-2 · Cited by 743
The head involution defective gene of Drosophila melanogaster functions in programmed cell death.
Grether, M. E., Abrams, J. M., Agapite, J., White, K., & Steller, H. (1995) · Genes & Development · doi:10.1101/gad.9.14.1694 · Cited by 699 · cited 1×
“Overexpression of Hid in the developing eye induces apoptosis and results in loss of eye structure”
BackgroundThe Ste20 group kinases as regulators of MAP kinase cascades
Dan, I., Watanabe, N. M., & Kusumi, A. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)01980-8 · Cited by 627 · cited 1×
“Here we show that Hippo (Hpo), the Drosophila homologue of the mammalian Ste20-like kinase”
BackgroundAnalysis of Drosophila photoreceptor axon guidance in eye-specific mosaics
Newsome, T. P., Åsling, B., & Dickson, B. J. (2000) · Development · doi:10.1242/dev.127.4.851 · Cited by 625
Cited by
Items 201–300 of 834
Targeting YAP and Hippo signaling pathway in liver cancer
Liu, A. M., Xu, Z., Chen, J., Poon, R. T. P., & Luk, J. M. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.499361 · Cited by 104
“After nuclear translocation, Yki interacts with transcription factors to regulate the expression of genes such as diap1 [12,13], cyclinE [10-13] and bantam microRNA [20,21] that are involved in cell proliferation and tissue growth, as well as Expanded (Ex) [22] and Kibra [23] that are the upstream components or regula…”
BackgroundMst1 and Mst2 kinases: regulations and diseases
Qin, F., Tian, J., Zhou, D., & Chen, L. (2013) · Cell & Bioscience · doi:10.1186/2045-3701-3-31 · Cited by 103
“The loss of function (LOF) mutant of the protein kinase “Hippo” exhibits tissues overgrowth and tumorigenesis, in which the increased cell number is associated with the acceleration of cell cycle progression and a failure of developmental apoptosis [1-5].”
BackgroundThe Hippo Pathway in Prostate Cancer
Salem, O., & Hansen, C. G. (2019) · Cells · doi:10.3390/cells8040370 · Cited by 102
The two sides of Hippo pathway in cancer
Li, F., & Guan, K. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.07.006 · Cited by 102
Wang, X., Stefanello, S. T., Shahin, V., & Qian, Y. (2025) · Advanced Materials · doi:10.1002/adma.202417564 · Cited by 102
Cell death in development: Signaling pathways and core mechanisms
Arya, R., & White, K. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.02.001 · Cited by 103
Rabizadeh, S., Xavier, R. J., Ishiguro, K., Bernabé-Ortiz, J. C., Lopez-Ilasaca, M. A., Khokhlatchev, A. V., Mollahan, P., Pfeifer, G. P., Avruch, J., & Seed, B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401699200 · Cited by 102
Hossain, M. S., Roy, A. S., & Islam, M. S. (2020) · Scientific Reports · doi:10.1038/s41598-020-71457-1 · Cited by 101
“RAS bound with RASSF5, activate MST1/2 35,44 to form STK3/MST2 and STK4/MST1 complexes in the hippo signaling pathway that plays a crucial role in tumor suppression by limiting proliferation and stimulating apoptosis where SAV1, MOB1A/B act as effector molecules 45,46 .”
BackgroundEpigenetic Regulation of the Wnt/β-Catenin Signaling Pathway in Cancer
Sharma, A., Mir, R., & Galande, S. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.681053 · Cited by 101
MST1/MST2 Protein Kinases: Regulation and Physiologic Roles
Galan, J. A., & Avruch, J. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00763 · Cited by 98
Herranz, H., Hong, X., & Cohen, S. M. (2012) · Current Biology · doi:10.1016/j.cub.2012.02.050 · Cited by 97
“The stocks used are described in the following references: MS1096-Gal4 [54], nub-Gal4 and ap-Gal4 [55], ptc-Gal4 [56], UAS-yki [5], UAS-EGFR [57], UAS-hpo [58], UAS-EGFR [59], UAS-RasV12 [38], UAS-EGFR (ID number: 43267, Vienna Drosophila RNAi Center), UAS-bantam-GFP”
The Hippo transducers TAZ and YAP in breast cancer: oncogenic activities and clinical implications
Maugeri‐Saccà, M., Barba, M., Pizzuti, L., Vici, P., Lauro, L. D., Dattilo, R., Vitale, I., Bartucci, M., Mottolese, M., & Maria, R. D. (2015) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2015.12 · Cited by 96
Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy
Juan, W., & Hong, W. (2016) · Genes · doi:10.3390/genes7090055 · Cited by 85
The Hippo signaling pathway provides novel anti-cancer drug targets
Bae, J. S., Kim, S. M., & Lee, H. (2016) · Oncotarget · doi:10.18632/oncotarget.14306 · Cited by 96
Cell Competition Time Line: Winners Kill Losers, which Are Extruded and Engulfed by Hemocytes
Lolo, F.-N., Casas-Tintó, S., & Moreno, E. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.08.012 · Cited by 87
“assay was performed as previously described (Udan et al., 2003), complementary to cleaved Caspase-3 staining.”
MethodRole of extracellular matrix and YAP/TAZ in cell fate determination
Hao, J., Zhang, Y., Wang, Y., Ye, R., Qiu, J., Zhao, Z., & Li, J. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.11.006 · Cited by 95
Zhang, X., Milton, C. C., Humbert, P. O., & Harvey, K. F. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4592 · Cited by 84
Intersection of Hippo/YAP and Wnt/β-catenin signaling pathways
Konsavage, W. M., & Yochum, G. S. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gms084 · Cited by 94
Hippo Signaling in Cancer: Lessons From Drosophila Models
Snigdha, K., Gangwani, K. S., Lapalikar, G. V., Singh, A., & Kango-Singh, M. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00085 · Cited by 79
Self-citationHippo pathway - brief overview of its relevance in cancer.
Zygulska, A. L., Krzemieniecki, K., & Pierzchalski, P. (2017) · PubMed · Cited by 94
YAP inhibits ERα and ER+ breast cancer growth by disrupting a TEAD-ERα signaling axis
Li, X., Zhuo, S., Zhuang, T., Cho, Y. S., Wu, G., Liu, Y., Mu, K., Zhang, K., Su, P., Yang, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30831-5 · Cited by 76
The Hippo Pathway Regulates Caveolae Expression and Mediates Flow Response via Caveolae
Rausch, V., Bostrom, J. R., Park, J., Bravo, I. R., Feng, Y., Hay, D. C., Link, B. A., & Hansen, C. G. (2018) · Current Biology · doi:10.1016/j.cub.2018.11.066 · Cited by 94
Emerging role of the Hippo pathway in autophagy
Wang, D., He, J., Huang, B., Liu, S., Zhu, H., & Xu, T. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03069-6 · Cited by 92
Hippo signaling instructs ectopic but not normal organ growth
Kowalczyk, W., Romanelli, L., Atkins, M., Hillen, H., Bravo González-Blas, C., Jacobs, J., Xie, J., Soheily, S., Verboven, E., Moya, I. M., et al. (2022) · Science · doi:10.1126/science.abg3679 · Cited by 86
Self-citationNore1 and RASSF1 Regulation of Cell Proliferation and of the MST1/2 Kinases
Avruch, J., Praskova, M. D., Ortiz-Vega, S., Liu, M., & Zhang, X. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)07025-4 · Cited by 92
Hippo signalling in the G2/M cell cycle phase: Lessons learned from the yeast MEN and SIN pathways
Hergovich, A., & Hemmings, B. A. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2012.04.001 · Cited by 92
“Considering the impact of initial studies on the Ste20-like Hippo kinase [26,55-58], Hippo/Mats/Lats signalling has been referred to as Hippo signalling ever since.”
BackgroundThe Hippo Signaling Pathway in the Regulation of Skeletal Muscle Mass and Function
Watt, K. I., Goodman, C. A., Hornberger, T. A., & Gregorevic, P. (2018) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000142 · Cited by 78
“Suppressor kinase 1 and 2 (Lats1/2) and/or the related kinases NDR1/2 (12, 14-16).”
BackgroundActivation mechanisms of the Hippo kinase signaling cascade
Bae, S. J., & Luo, X. (2018) · Bioscience Reports · doi:10.1042/bsr20171469 · Cited by 92
The regulation of Yorkie, YAP and TAZ: new insights into the Hippo pathway
Manning, S. A., Kroeger, B., & Harvey, K. F. (2020) · Development · doi:10.1242/dev.179069 · Cited by 90
“1, Table 1) comprises the kinases Hippo [MST1 and MST2 (also known as STK4 and STK3, respectively)] and Warts (LATS1 and LATS2), and the non-catalytic adaptors Salvador (SAV1) and Mats [MOBKL1A and MOBKL1B (also known as MOB1B and MOB1A, respectively)] (Tapon et al., 2002; Harvey et al., 2003; Wu et al., 2003; Kango-S…”
BackgroundControlling the size of organs and organisms
Leevers, S. J., & McNeill, H. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.09.008 · Cited by 90
The MST/Hippo Pathway and Cell Death: A Non-Canonical Affair
Fallahi, E., O’Driscoll, N., & Matallanas, D. (2016) · Genes · doi:10.3390/genes7060028 · Cited by 89
“In particular, active Hpo was shown to promote the transcription of the pro-apoptotic gene Head involution defective (Hip) resulting in the activation of apoptosis [51].”
BackgroundThe Hippo Signaling Pathway in Drug Resistance in Cancer
Zeng, R., & Dong, J. (2021) · Cancers · doi:10.3390/cancers13020318 · Cited by 89
Stem cell regulation by the Hippo pathway
Hiemer, S. E., & Varelas, X. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.07.005 · Cited by 89
Sopko, R., & McNeill, H. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.07.001 · Cited by 89
The Atypical Cadherin Fat Directly Regulates Mitochondrial Function and Metabolic State
Sing, A. D., Tsatskis, Y., Fabian, L., Hester, I., Rosenfeld, R., Serricchio, M., Yau, N., Bietenhader, M., Shanbhag, R., Jurisicova, A., et al. (2014) · Cell · doi:10.1016/j.cell.2014.07.036 · Cited by 88
Compartments and the control of growth in theDrosophilawing imaginal disc
Martín, F. A., & Morata, G. (2006) · Development · doi:10.1242/dev.02618 · Cited by 87
“staining were performed as described (Wang et al., 1999; Udan et al., 2003).”
MethodThe history and regulatory mechanism of the Hippo pathway
Kim, W., & Jho, E. (2018) · BMB Reports · doi:10.5483/bmbrep.2018.51.3.022 · Cited by 87
“The next substantial advance in the size-control mechanism was the discovery of the Hippo (Hpo) tumor suppressor gene, which encodes Ste-20 family protein kinase and is the homolog of MST1 and MST2 in humans (36-40).”
BackgroundThe Hippo tumor-suppressor pathway regulates apical-domain size in parallel to tissue growth
Hamaratoglu, F., Gajewski, K., Sansores-Garcia, L., Morrison, C., Tao, C., & Halder, G. (2009) · Journal of Cell Science · doi:10.1242/jcs.046482 · Cited by 78
“Ft function requires the FERM domain adaptor protein Expanded (Ex) and the unconventional myosin Dachs (D) (Bennett and Harvey, 2006; Cho et al., 2006; Cho and Irvine, 2004; Mao et al., 2006; Silva et al., 2006; Willecke et al., 2006; Willecke et al., 2008).”
BackgroundSelf-citationThe Hippo signalling pathway maintains quiescence in Drosophila neural stem cells
Ding, R., Weynans, K., Bossing, T., Barros, C. S., & Berger, C. (2016) · Nature Communications · doi:10.1038/ncomms10510 · Cited by 84
“To ensure that this phenotype is not because of an impaired entry into quiescence, we analysed trans-heterozygous hpo JM1 /hpo KC202 mutants 30,31 at hatching (0–2 h ALH) and 4 h ALH (Supplementary Fig.”
Regulation of the Hippo pathway in cancer biology
Moon, S., Park, S. Y., & Park, H. W. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2804-1 · Cited by 83
Zhang, P., Wang, T., Zhang, D., Zhang, Z., Yuan, S., Zhang, J., Cao, J., Li, H., Li, X., Shen, H., et al. (2019) · Translational Stroke Research · doi:10.1007/s12975-019-00702-1 · Cited by 82
The Hippo/YAP1 pathway interacts with FGFR1 signaling to maintain stemness in lung cancer
Lü, T., Li, Z., Yang, Y., Ji, W., Yu, Y., Niu, X., Zeng, Q., Xia, W., & Lu, S. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.02.015 · Cited by 82
The Hippo Pathway as a Driver of Select Human Cancers
Kulkarni, A., Chang, M. T., Vissers, J. H. A., Dey, A., & Harvey, K. F. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.04.004 · Cited by 81
Targeting the Hippo pathway in cancer
Harvey, K. F., & Tang, T. T.-L. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01234-0 · Cited by 80
“Drosophila )) and the LATS1/2 kinases (Warts in Drosophila ) to activate LATS1/2 kinase activity 1–8 , 68 .”
Tan, G., Cao, X., Dai, Q., Zhang, B., Huang, J., Xiong, S., Zhang, Y. Y., Chen, W., Yang, J., & Li, H. (2015) · Oncotarget · doi:10.18632/oncotarget.3254 · Cited by 80
“Hippo pathway inactivation and the subsequent nuclear translocations of YAP and TAZ have been shown to promote cell proliferation and resistance to death [31, 32].”
BackgroundThe Hippo pathway regulates stem cell proliferation, self-renewal, and differentiation
Liu, H., Jiang, D., Chi, F., & Zhao, B. (2012) · Protein & Cell · doi:10.1007/s13238-012-2919-3 · Cited by 80
Chronic liver inflammation and hepatocellular carcinoma: persistence matters
Boege, Y., Reisinger, F., & Heikenwälder, M. F. (2011) · Swiss Medical Weekly · doi:10.4414/smw.2011.13197 · Cited by 80
Hippo signaling pathway and organ size control
Zhang, L., Yue, T., & Jiang, J. (2009) · Fly · doi:10.4161/fly.3.1.7788 · Cited by 79
A Review: Molecular Aberrations within Hippo Signaling in Bone and Soft-Tissue Sarcomas
Deel, M. D., Li, J., Crose, L. E. S., & Linardic, C. M. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00190 · Cited by 79
“Canonical Hippo transduction involves serine/threonine kinases mammalian STE20-like protein kinase 1/2 (MST1/2, which are homologs of Drosophila Hippo) (4, 5, 11, 12) and large tumor suppressor homolog 1/2 (LATS1/2) (7, 13, 14), which, in conjunction with adaptor proteins Salvador homolog 1 (SAV1) (12) and Mob kinase…”
BackgroundRecent Advances of the Hippo/YAP Signaling Pathway in Brain Development and Glioma
Ouyang, T., Meng, W., Li, M., Hong, T., & Zhang, N. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00762-9 · Cited by 79
TAZ and YAP are frequently activated oncoproteins in sarcomas
Fullenkamp, C. A., Hall, S. L., Jaber, O. I., Pakalniskis, B. L., Savage, E. C., Savage, J. M., Ofori-Amanfo, G. K., Lambertz, A. M., Ivins, S. D., Stipp, C. S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8979 · Cited by 78
“[1, 2] The Hippo pathway is a series of core serine/threonine kinases including the STE20-like protein kinases 1 and 2 (MST1/2) [3-6] and the large tumor suppressor 1 and 2 (LATS1/2) [7, 8].”
BackgroundCai, W., Lin, L., Hao, H., Zhang, S., Ma, F., Hong, X., Zhang, H., Liu, Q., Ye, G., Sun, G., et al. (2017) · Hepatology · doi:10.1002/hep.28911 · Cited by 76
“Hippo signaling is an evolutionarily conserved pathway that regulates diverse cellular processes, including cell survival, proliferation, differentiation, and organ size.((1-6)) In mammals, the key components of Hippo signaling include two kinases, mammalian STE20-like protein kinase (MST) 1 and 2 and large tumor supp…”
BackgroundHuang, H.-L., Wang, S., Yin, M.-X., Dong, L., Wang, C., Wu, W., Lu, Y., Feng, M., Dai, C.-Y., Guo, X., et al. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001620 · Cited by 78
The DeMSTification of Mammalian Ste20 Kinases
Radu, M., & Chernoff, J. (2009) · Current Biology · doi:10.1016/j.cub.2009.04.022 · Cited by 76
“Here, genetic screens for flies with defects in organ size identified Hippo, the Mst1/2 ortholog, as a key regulator of cell growth and survival [8,9].”
Wbp2 cooperates with Yorkie to drive tissue growth downstream of the Salvador–Warts–Hippo pathway
Zhang, X., Milton, C. C., Poon, C. L. C., Hong, W., & Harvey, K. F. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.6 · Cited by 76
Hippo signaling promotes JNK-dependent cell migration
Ma, X., Wang, H., Ji, J., Xu, W., Sun, Y., Li, W., Zhang, X., Chen, J., & Xue, L. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1621359114 · Cited by 76
Hippo signaling: A hub of growth control, tumor suppression and pluripotency maintenance
Yin, M.-X., & Zhang, L. (2011) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2011.09.009 · Cited by 75
“Pantalacci et al., 2003; Udan et al., 2003; Wu et al., 2003).”
BackgroundThe β-catenin/YAP signaling axis is a key regulator of melanoma-associated fibroblasts
Liu, T., Zhou, L., YANG, K. Y., Iwasawa, K., Kadekaro, A. L., Takebe, T., Andl, T., & Zhang, Y. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0100-7 · Cited by 74
Hippo pathway in mammary gland development and breast cancer
Shi, P., Feng, J. C., & Chen, C. (2014) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmu114 · Cited by 74
“The Hippo pathway is believed to be a pivotal pathway that controls organ size in Drosophila and mammals by coordination of cell proliferation and survival [15,28–40] (Fig.”
BackgroundJin, Y., Xu, J., Yin, M.-X., Lu, Y., Hu, L., Li, P., Zhang, P., Yuan, Z., Ho, M. S., Ji, H., et al. (2013) · eLife · doi:10.7554/elife.00999 · Cited by 65
“Hpo is a serine/threonine Ste20-like kinase (Harvey et al., 2003; Jia et al., 2003; Pantalacci et al., 2003; Udan et al., 2003; Wu et al., 2003) that directly phosphorylates and activates downstream nuclear Dbf2related (NDR) family protein kinase Warts (Wts).”
BackgroundMask Proteins Are Cofactors of Yorkie/YAP in the Hippo Pathway
Sidor, C., Brain, R., & Thompson, B. J. (2013) · Current Biology · doi:10.1016/j.cub.2012.11.061 · Cited by 73
“TheHippo signaling pathway is an emerging tumor suppressor pathway in Drosophila [4–11] and mice [12–14].”
Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance
Wang, D., Wu, Y., Huang, J., Wang, W., Xu, M., Jia, J., Han, G., Mao, B., & Bi, W. (2016) · 癌症:英文版 · doi:10.1186/s40880-016-0109-z · Cited by 73
Hippo signaling in the kidney: the good and the bad
Wong, J. S., Meliambro, K., Ray, J., & Campbell, K. N. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00500.2015 · Cited by 67
“MST is activated in a phosphorylation-dependent manner by upstream tumor suppressors NF2/Merlin and KIBRA (1, 16, 22, 40, 72, 76).”
Merritt, N. M., Garcia, K. C., Rajendran, D., Lin, Z., Zhang, X., Mitchell, K. A., Borcherding, N. C., Fullenkamp, C. A., Chimenti, M. S., Gingras, A., et al. (2021) · eLife · doi:10.7554/elife.62857 · Cited by 72
YAP regulates neuronal differentiation through Sonic hedgehog signaling pathway
Lin, Y.-T., Ding, J.-Y., Li, M., Yeh, T.-S., Wang, T., & Yu, J. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.05.005 · Cited by 72
Zhao, M., Szafranski, P., Hall, C. A., & Goode, S. (2008) · Genetics · doi:10.1534/genetics.108.086983 · Cited by 69
Recent advances in searching c-Myc transcriptional cofactors during tumorigenesis
Caforio, M., Sorino, C., Iacovelli, S., Fanciulli, M., Locatelli, F., & Folgiero, V. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0912-2 · Cited by 70
Huerta-López, C., & Alegre‐Cebollada, J. (2021) · Nanomaterials · doi:10.3390/nano11071656 · Cited by 70
YAP/TAZ in Bone and Cartilage Biology
Zarka, M., Haÿ, E., & Cohen-Solal, M. E. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.788773 · Cited by 70
“, 2002), Hippo (Harvey et al., 2003; Jia et al., 2003; Pantalacci et al., 2003; Udan et al., 2003; Wu et al., 2003), and Mats (Lai et al.”
BackgroundEnomoto, M., Siow, K. M., & Igaki, T. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-0529-0_10 · Cited by 70
NEDD4 controls intestinal stem cell homeostasis by regulating the Hippo signalling pathway
Bae, S. J., Kim, M., Kim, S.-H., Kwon, Y. E., Lee, J.-H., Kim, J., Chung, C. H., Lee, W., & Seol, J. H. (2015) · Nature Communications · doi:10.1038/ncomms7314 · Cited by 69
Cho, Y. S., Li, S., Wang, X., Zhu, J., Zhuo, S., Han, Y., Yue, T., Yang, Y., & Jiang, J. (2019) · Genes & Development · doi:10.1101/gad.333146.119 · Cited by 69
“The core Hippo signaling pathway contains a kinase cassette with an upstream kinase Hippo (Hpo)/MST1/2 phosphorylating and activating a downstream kinase Warts (Wts)/Lats1/2 (Harvey et al. 2003; Jia et al. 2003; Pantalacci et al. 2003; Udan et al. 2003; Wu et al. 2003).”
BackgroundRegulation ofDrosophilaglial cell proliferation by Merlin-Hippo signaling
Reddy, B. V. V. G., & Irvine, K. D. (2011) · Development · doi:10.1242/dev.069385 · Cited by 68
“Although the role of Salvador has previously been suggested as being to promote phosphorylation of Wts by Hpo (Harvey et al., 2003; Pantalacci et al., 2003; Udan et al., 2003; Wu et al., 2003), our observations suggest that Sav might also have a distinct role in facilitating MerHippo signaling.”
BackgroundRegulators of mammalian Hippo pathway in cancer
Liu, A. M., Wong, K., Jiang, X., Qiao, Y., & Luk, J. M. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.05.006 · Cited by 68
Enomoto, M., & Igaki, T. (2011) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2011.09.005 · Cited by 68
“In addition, the core HpoeWts cascade is not required for the activation of YAP/TAZ by altered mechanical tension (Dupont et al., 2011).”
InfluentialFrequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequences
Schagdarsurengin, U., Richter, A. M., Hornung, J., Lange, C., Steinmann, K., & Dammann, R. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-264 · Cited by 68
“melanogaster, which regulates cell proliferation and apoptosis [21,25].”
BackgroundMorgan, E. L., Patterson, M. R., Ryder, E. L., Lee, S., Wasson, C. W., Harper, K. L., Li, Y., Griffin, S. D. C., Blair, G. E., Whitehouse, A., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008624 · Cited by 68
Dmp53 Activates the Hippo Pathway to Promote Cell Death in Response to DNA Damage
Colombani, J., Polesello, C., Josué, F., & Tapon, N. (2006) · Current Biology · doi:10.1016/j.cub.2006.05.059 · Cited by 68
Pfleger, C. M. (2017) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2016.12.001 · Cited by 67
Targeting ubiquitination in disease and therapy
Yang, X., Lan, T., Zhang, B., Tao, X., Qi, W., Xie, K., Cai, Y., Liu, C., Han, J., & Wu, H. M. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02392-8 · Cited by 67
“318 In mammals, the Hippo kinases include mammalian STE20-like protein kinases 1 (MST1) and MST2, whereas the Warts kinases include the large tumor suppressors LATS1 and LATS2.”
Hirabayashi, S., Nakagawa, K., Sumita, K., Hidaka, S., Kawai, T., Ikeda, M., Kawata, A., Ohno, K., & Hata, Y. (2008) · Oncogene · doi:10.1038/onc.2008.66 · Cited by 66
MICALs in control of the cytoskeleton, exocytosis, and cell death
Zhou, Y., Gunput, R.-A. F., Adolfs, Y., & Pasterkamp, R. J. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0787-2 · Cited by 59
“Both genetically engineered mice and Drosophila models implicate NDR and MST kinases in apoptosis regulation in vivo [66–76].”
BackgroundOverlapping functions of the MAP4K family kinases Hppy and Msn in Hippo signaling
Li, S., Cho, Y. S., Yue, T., Ip, Y. T., & Jiang, J. (2015) · Cell Discovery · doi:10.1038/celldisc.2015.38 · Cited by 65
Dutta, S., & Baehrecke, E. H. (2008) · Current Biology · doi:10.1016/j.cub.2008.08.052 · Cited by 60
Ovulatory signals alter granulosa cell behavior through YAP1 signaling
Sun, T., & Díaz, F. J. (2019) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-019-0552-1 · Cited by 64
Homeodomain-Interacting Protein Kinase Regulates Yorkie Activity to Promote Tissue Growth
Chen, J., & Verheyen, E. M. (2012) · Current Biology · doi:10.1016/j.cub.2012.06.074 · Cited by 64
“ca [13, 14] to initiate expression of the target genes, including Drosophila inhibitor of apoptosis protein 1 (Diap1), cyclin E (CycE), wingless (wg), and the Hpo agonist Expanded (ex) [15–18].”
Zhu, C., Ji, X., Zhang, H., Zhou, Q., Cao, X., Tang, M., Si, Y., Yan, H., Li, L., Liang, T., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000392 · Cited by 64
“mutant lacking 400 amino acids (1-1548) lost interaction with LATS2 (Fig.”
BackgroundInfluentialGailite, I., Aerne, B. L., & Tapon, N. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505512112 · Cited by 55
The Hippo pathway controls polar cell fate through Notch signaling during Drosophila oogenesis
Chen, H.-J., Wang, C.-M., Wang, T., Liaw, G., Hsu, T.-H., Lin, T.-H., & Yu, J. (2011) · Developmental Biology · doi:10.1016/j.ydbio.2011.07.003 · Cited by 63
“Hpo is an Ste20-like kinase that forms a complex with the adaptor protein Sav and phosphorylates Wts, a nuclear Dbf2-related (NDR) family kinase (Harvey et al., 2003; Justice et al., 1995; Pantalacci et al., 2003; Udan et al., 2003; Watson, 1995;Wu et al., 2003).”
Morgan, J. T., Murphy, C. J., & Russell, P. (2013) · Experimental Eye Research · doi:10.1016/j.exer.2013.06.012 · Cited by 57
“Salvador (Sav) complex together and initiate the Hippo cascade (Harvey et al., 2003; Jia et al., 2003; Kango-Singh et al., 2002; Pantalacci et al., 2003; Tapon et al., 2002; Udan et al., 2003; Wu et al., 2003).”
Nogueira, E., Fidalgo, M., Molnar, A., Kyriakis, J. M., Force, T. L., Zalvide, J. B., & Pombo, C. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709724200 · Cited by 63
Li, J., Du, X., Shi, H., Deng, K., Chi, H., & Tao, W. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.668442 · Cited by 63
Zhang, Q., Han, X., Chen, J., Xie, X., Xu, J., Zhao, Y., Shen, J., Hu, L. T., Xu, P., Song, H., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004251 · Cited by 63
The Hippo Pathway Regulates Homeostatic Growth of Stem Cell Niche Precursors in the Drosophila Ovary
Sarikaya, D. P., & Extavour, C. G. M. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1004962 · Cited by 62
“When the core kinase cascade is active, the kinase Hippo (Hpo) phosphorylates the kinase Warts (Wts) [19,20].”
BackgroundStructural and functional insights into the TEAD-YAP complex in the Hippo signaling pathway
Chen, L., Loh, P. G., & Song, H. (2010) · Protein & Cell · doi:10.1007/s13238-010-0138-3 · Cited by 62
“…WW-domain-containing protein, which acts as a © Higher Education Press and Springer-Verlag Berlin Heidelberg 2010 1073 scaffold to assemble the entire signaling complex containing Hpo and Warts (Wts), an NRD (nuclear Dbf2-related) family protein kinase (Harvey et al., 2003; Udan et al., 2003) (Fig.”
BackgroundMammalian Sterile20-like kinase 1 and the regulation of apoptosis
de Souza, P. M., & Lindsay, M. A. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320485 · Cited by 54
A Drosophila Tumor Suppressor Gene Prevents Tonic TNF Signaling through Receptor N-Glycosylation
de Vreede, G., Morrison, H. A., Houser, A. M., Boileau, R. M., Andersen, D. S., Colombani, J., & Bilder, D. H. (2018) · Developmental Cell · doi:10.1016/j.devcel.2018.05.012 · Cited by 61
“The ‘hyperplastic’ TSGs --including hippo, warts, and salvador—uncovered the novel Hippo (Hpo) signal transduction pathway that is now recognized as a conserved growth control mechanism (Harvey et al., 2003; Jia et al., 2003; Justice et al., 1995; Kango-Singh et al., 2002; Pantalacci et al., 2003; Tapon et al., 2002;…”
BackgroundXiong, J., Cui, X.-F., Yuan, X., Yu, X., Sun, J., & Gong, Q. (2015) · Journal of Experimental Botany · doi:10.1093/jxb/erv538 · Cited by 61
“The dramatic tissue overgrowth phenotype was observed in the mosaic eyes and wing discs, in which cells homozygous for hpo maintain a higher proliferation rate over their neighboring wild-type cells (Harvey et al., 2003; Jia et al., 2003; Pantalacci et al., 2003; Udan et al., 2003; Wu et al., 2003).”
BackgroundSalcedo, M. T., Zerón-Medina-Cuairán, J., Hernández‐Losa, J., Macarulla, T. M., Balsells, J., Merino, X., Allende, H., Tabernero, J. M., & y Cajal, S. R. (2017) · Pancreas · doi:10.1097/mpa.0000000000000867 · Cited by 61
The Hippo pathway: Organ size control and beyond
Guo, P., Wan, S., & Guan, K. (2024) · Pharmacological Reviews · doi:10.1016/j.pharmr.2024.100031 · Cited by 60
Metadata
- Authors
- Udan, R. S., Kango-Singh, M., Nolo, R., Tao, C., & Halder, G.
- Affiliations
- Baylor College of Medicine (US)
- The University of Texas MD Anderson Cancer Center (US)
- Corresponding author
- Halder, Georg
- Venue
- Nature Cell Biology
- Published
- 2003-09-21
- Volume
- 5
- Issue
- 10
- Pages
- 914-920
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- OpenAlex
- W2033440293
- Cited by
- 747
- References
- 34
- Citations by year
- 2026: 31 · 2025: 25 · 2024: 35 · 2023: 26 · 2022: 41 · 2021: 45 · 2020: 53 · 2019: 32 · 2018: 55 · 2017: 34 · 2016: 37 · 2015: 46 · 2014: 36 · 2013: 37 · 2012: 34
- FWCI
- 6.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- BearWorks (Missouri State University) (submittedVersion)
- Lirias (KU Leuven) (submittedVersion)
- Funders
- National Cancer Institute (CA-16672, P30CA016672)
- National Institute of General Medical Sciences (R01GM067997, GM067997)
- National Institute of Environmental Health Sciences (T32 ES07332, T32ES007332)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD07325)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- cell proliferation, apoptosis, cyclin E, DIAP1, head involution defective, Warts kinase, Ste20-like kinase, Drosophila development, cell number regulation
- MeSH terms
- Hippo Kinases, Animals, Cell Division, Drosophila melanogaster, Female, Male, Morphogenesis, Protein Kinases, Wings, Animal, Signal Transduction, Apoptosis, Protein Serine-Threonine Kinases, Cell Cycle Proteins, MAP Kinase Kinase Kinases, Saccharomyces cerevisiae Proteins, Drosophila Proteins, Animals, Genetically Modified, Intracellular Signaling Peptides and Proteins, Inhibitor of Apoptosis Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.